Categories AlphaGraphs, Earnings, Technology

QCOM Earnings: Qualcomm Q2 revenues rise 41%; profit tops expectations

Chipmaker Qualcomm, Inc. (NASDAQ: QCOM) on Wednesday reported stronger-than-expected earnings and revenues for the second quarter of 2022 amid continued uptick in microprocessor demand across industries. The company also provided guidance for the third quarter.

Qualcomm Q2 2022 earnings infographic

At $11.2 billion, second-quarter revenues were up 41% from the prior-year quarter and well above the consensus forecast. The top line benefited from elevated chip demand and the company’s investments in 5G technology.

Net income was $2.93 billion or $2.57 per share, compared to $1.76 billion or $1.53 per share in the second quarter of 2021. Adjusted profit moved up to $3.21 per share from $1.90 per share last year and topped the Street view.


Check this space to read management/analysts’ comments on Qualcomm’s Q2 results


Qualcomm’s shares dropped around 27% since the beginning of the year. Following the earnings announcement, the stock made strong gains Wednesday evening, after closing the regular session higher.

Prior Performance

  • Qualcomm reports Q1 2022 earnings results
  • Qualcomm Q4 2021 earnings infographic

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top